Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $12.38 Billion |
|---|---|
| Enterprise Value | $12.15 Billion |
| Annual dividend | $0.11 |
| Dividend yield | 1.06% |
| Earnings per Share | $0.32 |
| Beta | 0.62 |
| Outstanding Shares | 1,177,429,000 |
| P/E Ratio | 23.61 |
|---|---|
| PEG | 58.4 |
| Price to Sales | 1.62 |
| Price to Book Ratio | 3.25 |
| Enterprise Value to Revenue | 1.5 |
| Enterprise Value to EBIT | 10.67 |
| Enterprise Value to Net Income | 14 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.1 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems...